美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Global X Aging Population ETF

37.09

+0.49761.36%

盤後：36.58-0.5070-1.37%16:43 EDT

成交量：7,683

成交額：28.49萬

市值：9,159.45萬

市盈率：- -

高：37.24

開：37.02

低：37.02

收：36.59

52周最高：39.48

52周最低：32.44

股本：246.97萬

流通股本：246.97萬

量比：1.05

換手率：0.31%

股息：0.33

股息率：0.89%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

山東省寧陽縣市場監管局開展醫療器械專項現場檢查

中国质量新闻网

又一家醫療器械企業登陸港股，麥科田(02041)「含金量」幾何？

從美妝到生物科技公司植物醫生挺進大健康領域

高瓴重倉的醫療器械公司，IPO首日開盤跌超30%

海南出台醫療器械委託生產監管新政

格式塔創始人彭雷：三到五年內，腦機接口本質上是嚴肅的醫療器械

研究發現，美國越來越多的12歲以下兒童被開具減肥藥處方

服務退役軍人有成效，貴州企業獲國家級授牌！

聯邦制藥(03933.HK)：UBT251注射液完成中國超重/肥胖III期臨床研究首例試驗參與者給藥

里昂：生物科技行業基本面仍穩固，首選百濟神州、信達生物及維立志博

從護膚到大健康，植物醫生想成為一家生物科技公司

我國長期護理保險參保人數超3.2億

我國長期護理保險參保人數超3.2億

我國長期護理保險參保人數超3.2億

109億美元重磅收購Apogee(APGE.US)落地！艾伯維(ABBV.US)完成2019年以來最大併購，預計2032年起貢獻收益

109億美元重磅收購Apogee(APGE.US)落地！艾伯維(ABBV.US)完成2019年以來最大併購，預計2032年起貢獻收益

艾伯維公布Cervino三期試驗積極頂線結果：Etentamig顯著提升復發/難治性多發性骨髓瘤患者緩解率與無進展生存期

艾伯維的血液癌症藥物達到了晚期臨床試驗的目標

阿斯彭預計，2027年Mounjaro在非洲的銷售額將超過1.24億美元

Superluminal Medicines完成融資：Bvf Partners領投，英偉達、禮來等現有投資方跟投

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/stock/AGNG/news?page=3"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AGNG","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AGNG\",,,,,undefined,":{"symbol":"AGNG","market":"US","secType":"STK","nameCN":"Global X Aging Population ETF","latestPrice":37.087,"timestamp":1789416000000,"preClose":36.5894,"halted":0,"volume":7683,"hourTrading":{"tag":"盘后","latestPrice":36.58,"preClose":37.087,"latestTime":"16:43 EDT","volume":13,"amount":480.40902,"timestamp":1789418598118,"change":-0.507,"changeRate":-0.013671,"amplitude":0.013671},"delay":0,"changeRate":0.013599567087735947,"floatShares":2469721,"shares":2469721,"eps":0,"marketStatus":"盤後交易","change":0.4976,"latestTime":"09-14 18:29:06 EDT","open":37.02,"high":37.244,"low":37.02,"amount":284884.25706,"amplitude":0.006122,"askPrice":55.62,"askSize":200,"bidPrice":32.93,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1789430400000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":36.5894,"sharesOutstanding":2330000,"nav":36.55,"aum":90289519.63,"dividendRate":0.008879,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":36.58,"preClose":37.087,"latestTime":"16:43 EDT","volume":13,"amount":480.40902,"timestamp":1789418598118,"change":-0.507,"changeRate":-0.013671,"amplitude":0.013671},"volumeRatio":1.04542,"impliedVol":0.378,"impliedVolPercentile":0.8327},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AGNG\",,,,,undefined,":{"symbol":"AGNG","floatShares":2469721,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.04542,"shares":2469721,"dividePrice":0.3293,"high":37.244,"amplitude":0.006122,"preClose":36.5894,"low":37.02,"week52Low":32.4401,"pbRate":"--","week52High":39.48,"institutionHeld":0,"latestPrice":37.087,"committee":-0.333333,"eps":0,"divideRate":0.008879,"volume":7683,"delay":0,"ttmEps":0,"open":37.02,"prevYearClose":35.8964,"prevWeekClose":36.5894,"prevMonthClose":38.1173,"prevQuarterClose":36.0159,"fiveDayClose":38.2042,"twentyDayClose":38.0658,"sixtyDayClose":34.5716},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AGNG\",params:#limit:5,,,undefined,":[{"date":"2026-06-29","symbol":"AGNG","amount":0.155552,"announcedDate":"2026-06-26","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-29","defaultRemindTime":1782739800000,"name":"Global X Aging Population ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-07-07","payableDate":"2026-06-29","currency":"USD","dateTimestamp":1782705600000,"payDate":"2026-07-07"},{"date":"2025-12-30","symbol":"AGNG","amount":0.172198,"announcedDate":"2025-12-29","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-30","defaultRemindTime":1767105000000,"name":"Global X Aging Population ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-01-07","payableDate":"2025-12-30","currency":"USD","dateTimestamp":1767070800000,"payDate":"2026-01-07"},{"date":"2025-06-27","symbol":"AGNG","amount":0.14218,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-27","defaultRemindTime":1751031000000,"name":"Global X Aging Population ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-07","payableDate":"2025-06-27","currency":"USD","dateTimestamp":1750996800000,"payDate":"2025-07-07"},{"date":"2024-12-30","symbol":"AGNG","amount":0.14617,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-30","defaultRemindTime":1735569000000,"name":"Global X Aging Population ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-01-07","payableDate":"2024-12-30","currency":"USD","dateTimestamp":1735534800000,"payDate":"2025-01-07"},{"date":"2024-06-27","symbol":"AGNG","amount":0.10429,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-27","defaultRemindTime":1719495000000,"name":"Global X Aging Population ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-05","payableDate":"2024-06-27","currency":"USD","dateTimestamp":1719460800000,"payDate":"2024-07-05"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AGNG\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-28","recordDate":"2016-12-30","paymentDate":"2017-01-06","value":0.161273,"currency":"USD"},{"executeDate":"2021-06-29","recordDate":"2021-06-30","paymentDate":"2021-07-08","value":0.034042,"currency":"USD"},{"executeDate":"2021-12-30","recordDate":"2021-12-31","paymentDate":"2022-01-07","value":0.174268,"currency":"USD"},{"executeDate":"2022-06-29","recordDate":"2022-06-30","paymentDate":"2022-07-08","value":0.107236,"currency":"USD"},{"executeDate":"2022-12-29","recordDate":"2022-12-30","paymentDate":"2023-01-09","value":0.021742,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AGNG\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AGNG\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2665399937","title":"山東省寧陽縣市場監管局開展醫療器械專項現場檢查","url":"https://stock-news.laohu8.com/highlight/detail?id=2665399937","media":"中国质量新闻网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665399937?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 12:37","pubTimestamp":1788755820,"startTime":"0","endTime":"0","summary":"中国质量新闻网讯 9月7日，山东省宁阳县市场监管局执法人员深入辖区零售药店，开展医疗器械专项现场检查。执法人员重点查看血压计等二类医疗器械，仔细核对产品注册资料、进货票据，查验产品有效期、包装标识，排查有无过期失效、来路不明产品等风险隐患。检查过程坚持监管和指导同步开展，现场向药店从业人员讲解医疗器械经营相关规定，指出经营中的不足，督促经营者落实主体责任，规范进货查验和日常自查工作。下一步，该局将持续加大医疗器械监管频次，紧盯零售药店经营风险，切实保障群众用械安全。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-09-07/doc-iniqykzy9680694.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["PTH","RSPH","MEDX","BK1574","BK1100","HART","LNGR","AGNG","BK1583","GDOC","159883","IEIH","LGHT","09996","MDEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665399350","title":"又一家醫療器械企業登陸港股，麥科田(02041)「含金量」幾何？","url":"https://stock-news.laohu8.com/highlight/detail?id=2665399350","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665399350?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 12:07","pubTimestamp":1788754034,"startTime":"0","endTime":"0","summary":"随着多家医疗器械企业中报密集披露，医疗器械板块整体修复态势明确，业绩端已出现向上拐点。9月7日，麦科田正式于港交所挂牌上市，这意味着港股医疗器械板块再添一家平台型龙头。据多家权威机构测算，2026年全球医疗器械市场规模预计在6000亿至8000亿美元之间，并有望于2035年突破万亿美元大关。整体来看，麦科田此次登陆港股，业绩方面盈利拐点已经确认，商业化路径成熟，平台型的全面产品组合和全","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1492650.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["MDEV","AGNG","BK1583","BK1100","KCAI","RSPH","159883","MEDX","VXUS","PTH","GDOC","LNGR","02041","BK4588","LGHT","HART","IEIH","BK4585","BK1574","09996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665962333","title":"從美妝到生物科技公司 植物醫生挺進大健康領域","url":"https://stock-news.laohu8.com/highlight/detail?id=2665962333","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665962333?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 11:46","pubTimestamp":1788752760,"startTime":"0","endTime":"0","summary":"渠道红利退去、流量成本攀升、产品同质化加剧……中国美妆行业正经历从“快车道”到“窄门”的残酷转型。当“一招鲜”的战术红利消失，建立底层技术壁垒不再是可选项，而是生存项。当全行业 ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20260907/c679648733.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20260907/c679648733.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["MEDX","LNGR","BK4585","SYNB","IEIH","XBI","IBBJ","HBImain","BK4588","GDOC","AGNG","159837","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665968913","title":"高瓴重倉的醫療器械公司，IPO首日開盤跌超30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2665968913","media":"直通IPO","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665968913?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 11:01","pubTimestamp":1788750084,"startTime":"0","endTime":"0","summary":"然而，这家被高瓴资本重仓押注的企业，并未迎来开门红。上市首日，麦科田开盘即破发，股价报10港元/股，较发行价15.43港元大跌35.15%，总市值定格在53.86亿。值得注意的是，此次IPO未引入基石投资者。截至2026年3月31日，公司拥有320余款商业化医疗器械产品及60余款在研产品，覆盖全球逾140个国家及地区，经销商网络由2000余家经销商组成。尽管拥有强大的产业背景、稳健的基本面和明星机构背书，麦科田上市首日的股价表现依然不尽如人意。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2026/09/07110158370392.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["KCE","MDEV","MEDX","AGNG","IPOS","RSPH","159883","BK1583","BK1100","HART","REDS","09996","FRHC","BK1574","BK4127","PTH","LNGR","LGHT","IEIH","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665250366","title":"海南出台醫療器械委託生產監管新政","url":"https://stock-news.laohu8.com/highlight/detail?id=2665250366","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665250366?lang=zh_tw&edition=fundamental","pubTime":"2026-09-06 07:43","pubTimestamp":1788651815,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IEIH","AGNG","RSPH","LGHT","GDOC","LNGR","MEDX","HART","PTH","MDEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665350040","title":"格式塔創始人彭雷：三到五年內，腦機接口本質上是嚴肅的醫療器械","url":"https://stock-news.laohu8.com/highlight/detail?id=2665350040","media":"睿见Economy","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665350040?lang=zh_tw&edition=fundamental","pubTime":"2026-09-05 14:01","pubTimestamp":1788588060,"startTime":"0","endTime":"0","summary":"格式塔创始人、CEO彭雷表示，脑机接口赛道要解决的核心问题就一个：持续提高对脑内读写的分辨率。在他看来，至少在看得见的三到五年内，脑机接口本质上还是严肃的医疗器械，它的创新落地，付费方一定是医疗体系与患者。他指出，如何依托我国特色的医疗保障体系，让前沿的脑机接口应用纳入医保，惠及更多患者、解决实际病痛，这就是付费层面需要思考的问题。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/hy/hyjz/2026-09-05/doc-iniquccw0443893.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["GDOC","HART","IBRN","MDEV","LNGR","BK1583","MEDX","BK1100","AGNG","IEIH","MNTL","BK1574","LGHT","PTH","159883","RSPH","09996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665561483","title":"研究發現，美國越來越多的12歲以下兒童被開具減肥藥處方","url":"https://stock-news.laohu8.com/highlight/detail?id=2665561483","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665561483?lang=zh_tw&edition=fundamental","pubTime":"2026-09-05 02:45","pubTimestamp":1788547556,"startTime":"0","endTime":"0","summary":"研究发现，美国越来越多的12岁以下儿童被开具减肥药处方路透9月4日-据周五发表的一项研究显示，由于医生们正在为患有肥胖症的年轻患者寻求新的有效治疗方法，自2019年以来，美国12岁以下儿童的GLP-1减肥药处方量已增长了300多倍。该研究涵盖了350多万名8至11岁、患有肥胖症但未患糖尿病的儿童，结果显示GLP-1减肥药的处方率从2019年的0.03%上升至截至6月的9.3%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nL4T44W18V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1280957306.USD","LU2265009873.SGD","LU0640476718.USD","LU2213496289.HKD","LLY","LU0708995401.HKD","LU2357305700.SGD","LU1868837300.USD","LU2168563687.JPY","IE00B775H168.HKD","LU0109391861.USD","LU1814569148.SGD","LU2237443382.USD","IE00BKVL7J92.USD","IE00BKDWB100.SGD","IE0005OL40V9.USD","IE00BZ1G4Q59.USD","LU2491050154.USD","JDOC","LU0345770308.USD","TMED","LU1366192091.USD","SG9999017495.SGD","LU2417539215.USD","LU2756315318.SGD","SGXZ31699556.SGD","IE00BWXC8680.SGD","LU2462157665.USD","LU2896262040.SGD","HRTS","BK4533","LU2361045086.USD","SG9999014906.USD","SG9999001176.SGD","SG9999014898.SGD","LLYX","BK4516","LU0133085943.USD","BK4532","ELIL","LU2471134879.HKD","LU1093756325.SGD","IE00BJJMRZ35.SGD","LU2023251221.USD","LU2264538146.SGD","WDNA","LU2746668461.USD","LU1267930730.SGD","SGXZ81514606.USD","LU0154236417.USD","LU0158827781.USD","LU2236285917.USD","LU2746668974.SGD","LU2750360641.GBP","LU0786609619.USD","LU1868836757.USD","LU2168564065.EUR","MEDI","SG9999018865.SGD","LU2237438978.USD","BK4581","LU0823434583.USD","LU0114720955.EUR","LU2087625088.SGD","LU0787776722.HKD","LU2361044865.SGD","LU2456880835.USD","LU0097036916.USD","LU1069344957.HKD","LU1720051108.HKD","LU2063271972.USD","BK4599","IE0004445015.USD","LU0203202063.USD","LU2237443549.SGD","LU0203201768.USD","LU2750360997.AUD","BK4534","PJP","LU0106261372.USD","LU0061475181.USD","LU0320765059.SGD","LU0158827948.USD","LU2237443978.SGD","LU1988902786.USD","IE00BK4W5L77.USD","LU1917777945.USD","SG9999014914.USD","LU1061106388.HKD","LU0122379950.USD","SGXZ51526630.SGD","IXJ","LU0210536198.USD","CURE","LU2491050071.SGD","LU2168564222.USD","THNR","LU2108987350.USD","LU1323610961.USD","IE00BJLML261.HKD","LU0323591593.USD","LU1291159041.SGD","LU0672654240.SGD","IE00B1XK9C88.USD","IHE","LU0234572021.USD","IE00BJT1NW94.SGD","LU1720051017.SGD","LU2023250330.USD","LU0820561909.HKD","LU1989771016.USD","IE00B2B36J28.USD","LLYZ","LU2028103732.USD","LU2552382058.USD","LU0256863811.USD","LLII","LU1023059063.AUD","ELIS","IE00BJJMRX11.SGD","LU2168564495.EUR","LU2237443465.HKD","LU0943347566.SGD","LU1551013425.SGD","LU0289739699.SGD","LU1093756168.USD","BK4007","SG9999001176.USD","SG9999015952.SGD","LU0345770993.USD","LU0689472784.USD","IE00B4R5TH58.HKD","LU0466842654.USD","GDOC","LU0266013472.USD","LU1035775433.USD","LU1712237335.SGD","LU2552382132.HKD","FHLC","IE0002141913.USD","LU1868836914.USD","IE00BK4W5M84.HKD","LU2089284900.SGD","AGNG","LU2361044949.HKD","FTXH","LU0823434740.USD","LU0225283273.USD","LU0823416689.USD","SG9999015945.SGD","LU2471134952.CNY","LU1548497426.USD","SGXZ99366536.SGD","LU2211815571.USD","LU1868836591.USD","LU0079474960.USD","SG9999014880.SGD","OZEM","LU0316494557.USD","XLV","IE00BFSS7M15.SGD","LU0353189763.USD","LU1232071149.USD","LU2089283258.USD","IE00BN29S564.USD","IE0009355771.USD","LU0198837287.USD","LU2106854487.HKD","PPH","LU0354030438.USD","LU0882574055.USD","BK4585","LU1804176565.USD","LU2271345857.HKD","LU1629891620.HKD","LU2023250504.SGD","IE00BJJMRY28.SGD","LU0456855351.SGD","SG9999018857.SGD","LU0432979614.USD","IE00BKPKM429.USD","LU2111349929.HKD","LU2461242641.AUD","NVOH","LU0889565916.HKD","SG9999015978.USD","LU0471298777.SGD","LU2112291526.USD","LU2491049909.HKD","LU0174119429.USD","LU0882574139.USD","MHIP","IE0001KFT4U8.USD","LU1623119135.USD","SG9999013999.USD","CANC","LU2602419157.SGD","LU2471134796.USD","IE00B7KXQ091.USD","LU1691799644.USD","LU2756315664.SGD","NVOX","IE00BFSS8Q28.SGD","LU0320765992.SGD","LU1064131342.USD","LU1868837136.USD","VHT","LU1551013342.USD","LU0109394709.USD","LU1127390331.HKD","LU1974910355.USD","LU0683600562.USD","MEDX","ILDR","LU2552382215.SGD","LU0238689110.USD","BK4588","SGXZ57979304.SGD","LU1983299246.USD","LU0471298694.HKD","LU2471134523.USD","LU1057294990.SGD","LU0256863902.USD","TRUH","LU2168564149.EUR","LU0385154629.USD","IYH","LU0006306889.USD","SG9999015986.USD","LU0094547139.USD","LU2468319806.SGD","RXL","LU0058720904.USD","LU0353189680.USD","LU0354030511.USD","IE00BFTCPJ56.SGD","LU0964807845.USD","LU2462591350.SGD","IE00B1BXHZ80.USD","GB00BDT5M118.USD","IE0004445239.USD","LU2324357040.USD","LU0820561818.USD","LU2237443895.HKD","NVOC","LU2237443622.USD","IE00B4JS1V06.HKD","LU1145028129.USD","LU0820562030.AUD","NVO","LU0417517546.SGD","LU2360106947.USD","LU1979441026.SGD","LU0096364046.USD","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664633992","title":"服務退役軍人有成效，貴州企業獲國家級授牌！","url":"https://stock-news.laohu8.com/highlight/detail?id=2664633992","media":"滚动播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664633992?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 19:20","pubTimestamp":1788520800,"startTime":"0","endTime":"0","summary":"9月3日，中国退役军人就业创业服务促进会授牌仪式在贵阳举行。贵州省松平生物科技有限公司被授予“中国退役军人就业创业服务促进会副理事长单位”会员。据了解，贵州省松平生物科技有限公司为退役军人创办，主业聚焦生物制药、健康保健和职业培训。此次授牌，标志着该企业正式纳入全国退役军人就业创业服务体系，将获得促进会在资源对接、政策指导、人才培育、创业帮扶等多方面的专业支持，让企业能更好地帮助退役军人就业创业。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-09-04/doc-iniqskuq0832283.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IEIH","XBI","BK4588","GDOC","LNGR","HBImain","AGNG","BK4581","IBBJ","SYNB","BK4585","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664233645","title":"聯邦制藥(03933.HK)：UBT251注射液完成中國超重/肥胖III期臨床研究首例試驗參與者給藥","url":"https://stock-news.laohu8.com/highlight/detail?id=2664233645","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664233645?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 18:55","pubTimestamp":1788519354,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IBBJ","AGNG","IEIH","MEDX","GDOC","LNGR","XBI","SYNB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664381419","title":"里昂：生物科技行業基本面仍穩固，首選百濟神州、信達生物及維立志博","url":"https://stock-news.laohu8.com/highlight/detail?id=2664381419","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664381419?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 14:16","pubTimestamp":1788502604,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4526","LNGR","BK4139","BK4585","IEIH","XBI","MEDX","SYNB","BK4581","IBBJ","GDOC","ONC","AGNG","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664381446","title":"從護膚到大健康，植物醫生想成為一家生物科技公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2664381446","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664381446?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 12:39","pubTimestamp":1788496793,"startTime":"0","endTime":"0","summary":"从高山植物护肤，到中国原创成分，再到大健康产品，它正在尝试把高山植物科研从服务于单一护肤品的研发能力，变成一套能够跨品类持续产生价值的科研底座。这个问题的答案，将决定植物医生最终是增加了一条大健康产品线，还是能够真正完成从护肤品牌向生物科技公司的能力跃迁。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1788496062591431273","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["IBBJ","BK4581","IEIH","MEDX","159837","XBI","BK4585","LNGR","SYNB","AGNG","GDOC","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664959385","title":"我國長期護理保險參保人數超3.2億","url":"https://stock-news.laohu8.com/highlight/detail?id=2664959385","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664959385?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 10:46","pubTimestamp":1788489982,"startTime":"0","endTime":"0","summary":"金吾财讯 | 据新华社报道，国家医保局副局长王文君4日在国新办举行的“开局起步‘十五五’”系列主题新闻发布会上介绍，我国长期护理保险参保人数超3.2亿，基金累计支出1142亿元，为超过460万失能人员提供了护理服务。截至目前，22个省份印发省级实施方案，建制统筹地区达到121个，预计今年底全国将拓展至247个统筹地区。","market":"fut","thumbnail":"https://static.szfiu.com/news/20241108/Y2Y0ZjIxMzUyMzg0MDEwNQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/Y2Y0ZjIxMzUyMzg0MDEwNQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1990674","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664383767","title":"我國長期護理保險參保人數超3.2億","url":"https://stock-news.laohu8.com/highlight/detail?id=2664383767","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664383767?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 10:28","pubTimestamp":1788488907,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664383756","title":"我國長期護理保險參保人數超3.2億","url":"https://stock-news.laohu8.com/highlight/detail?id=2664383756","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664383756?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 10:28","pubTimestamp":1788488884,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664388058","title":"109億美元重磅收購Apogee(APGE.US)落地！艾伯維(ABBV.US)完成2019年以來最大併購，預計2032年起貢獻收益","url":"https://stock-news.laohu8.com/highlight/detail?id=2664388058","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664388058?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 09:35","pubTimestamp":1788485746,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MEDX","LU2129689605.HKD","IYH","LU1267930490.SGD","LU2129689514.USD","MYLD","PPH","APGE","FTXH","LU0114720955.EUR","LU1839511570.USD","IE00B19Z3B42.SGD","LU2237443895.HKD","LU1236620834.HKD","IXJ","PJP","LU2237443549.SGD","IE0002141913.USD","LU0128525929.USD","SBIO","GLAM","AGNG","SG9999003800.SGD","ABBV","LU0310800379.SGD","LU2125909593.SGD","LU2433249047.HKD","LU0320765646.SGD","BK4533","LU0069063385.USD","LU1496350502.SGD","KCE","LU0820561909.HKD","VHT","FHLC","LU2087621335.USD","XMMO","IE000WAW04H5.SGD","XLV","LU0234570918.USD","LU0859254822.USD","LU0203345920.USD","CALF","RXL","TRUH","LU0124676726.USD","LU1551013425.SGD","LU2089984988.USD","JDOC","LU0170899867.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664053388","title":"109億美元重磅收購Apogee(APGE.US)落地！艾伯維(ABBV.US)完成2019年以來最大併購，預計2032年起貢獻收益","url":"https://stock-news.laohu8.com/highlight/detail?id=2664053388","media":"智通财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664053388?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 09:35","pubTimestamp":1788485746,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，艾伯维于周四表示，公司已完成对抗炎药物研发商 Apogee Therapeutics价值 109 亿美元的收购。笔交易是这家制药巨头自 2019 年以来规模最大的补强型收购，智通财经AAPP于今年 6 月首次对此进行了报道。艾伯维预计，该项收购将对其调整后稀释每股收益产生负面影响，其中 2026 年将减少 0.14 美元，2027 年减少约 0.46 美元，并预计将于 2032 年开始实现增益。该指引已包含与完成 Apogee 收购相关的每股 0.14 美元稀释效应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1491888.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1037948541.HKD","LU1989772840.SGD","APGE","IYH","LU0203345920.USD","LU0124676726.USD","IE0004445239.USD","PJP","VHT","JDOC","LU1093756168.USD","TRUH","IE00BLSP4239.USD","FHLC","LU0170899867.USD","LU1934455194.USD","BK4559","GLAM","XMMO","LU0289739343.SGD","RXL","LU0057025933.USD","LU0985320562.USD","LU2089283258.USD","MYLD","XLV","PPH","BK4566","LU0256863902.USD","ABBV","LU1236620834.HKD","MEDX","LU1003077747.HKD","SBIO","FTXH","IE00BN8TJ469.HKD","IXJ","KCE","BK4581","LU0965509283.SGD","SG9999011175.SGD","AGNG","IE0002270589.USD","CALF","IE00B2B36J28.USD","IE00B4R5TH58.HKD","LU1718418525.SGD","IE00B19Z3581.USD","LU1983299246.USD","LU2237443549.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112455320","title":"艾伯維公布Cervino三期試驗積極頂線結果：Etentamig顯著提升復發/難治性多發性骨髓瘤患者緩解率與無進展生存期","url":"https://stock-news.laohu8.com/highlight/detail?id=1112455320","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112455320?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 21:19","pubTimestamp":1788441558,"startTime":"0","endTime":"0","summary":"艾伯维公司今日宣布，其针对复发或难治性多发性骨髓瘤患者的关键性Cervino三期临床试验，取得了积极的顶线数据。研究结果显示，在研药物Etentamig不仅显著提高了患者的客观缓解率，更在延长无进展生存期方面展现出压倒性的统计学优势。Cervino试验是一项全球性的、随机、开放标签的注册研究，旨在评估Etentamig相较于标准治疗的疗效与安全性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0689626769.HKD","LU1934455194.USD","LU2133065610.SGD","LU0211328371.USD","LU0738911758.USD","LU0861579265.USD","LU1037948897.HKD","IE000MB6IJN5.SGD","LU0965509283.SGD","LU1003077747.HKD","SG9999015978.USD","AGNG","IXJ","LU0985320562.USD","IE000SO60NU8.SGD","LU0114720955.EUR","LU1551013425.SGD","LU1732799900.SGD","LU0122379950.USD","LU0689472784.USD","LU0820561909.HKD","IE000F7OJYX1.SGD","LU0432979614.USD","IE00B4R5TH58.HKD","IE00B19Z3B42.SGD","LU1236620750.USD","GLAM","IE000WAW04H5.SGD","BK4588","BK4533","LU0820561818.USD","LU0949170772.SGD","LU0310799852.SGD","LU1585245621.USD","TRUH","IE0002270589.USD","SG9999003800.SGD","LU1934455863.HKD","LU2129689605.HKD","FTXH","BK4550","LU2125909593.SGD","LU0058720904.USD","LU1989771016.USD","LU0203345920.USD","LU0553294199.USD","IE00BLSP4452.SGD","LU0098860793.USD","LU0310800379.SGD","LU0124676726.USD","LU0868494617.USD","LU1732800096.USD","LU0289739699.SGD","IE00B19Z3581.USD","LU1244550577.SGD","IE0002141913.USD","LU0795875169.SGD","LU2237443622.USD","LU0708994859.HKD","IE00BVYPNW00.USD","LU1267930573.SGD","LU2129689514.USD","LU0472753341.HKD","IE00BLSP4239.USD","LU1496350502.SGD","LU2433249047.HKD","LU2023251221.USD","IE00BSNM7G36.USD","LU0198837287.USD","LU1989772923.USD","LU0859254822.USD","LU2237443978.SGD","BK4581","IE00BJT1NW94.SGD","LU0234572021.USD","IE0004445239.USD","LU1244550221.USD","LU0456855351.SGD","LU1093756168.USD","LU0203347892.USD","LU2237443549.SGD","LU1244550494.USD","LU1718418525.SGD","LU1023059063.AUD","LU2087621335.USD","LU1236620834.HKD","LU2237443895.HKD","PJP","SG9999011175.SGD","IE00B3PB1722.GBP","LU0965508806.USD","LU0158827948.USD","IE00BJJMRZ35.SGD","LU0417517546.SGD","XLV","LU2089284900.SGD","LU2129689431.USD","LU0289961442.SGD","IE0009355771.USD","LU1430594728.SGD","FHLC","LU1983299246.USD","IE00B42XCP33.USD","LU1037948541.HKD","LU0965509010.AUD","LU0289739343.SGD","IE0000B7K699.USD","IE000BZT7R73.USD","LU0234570918.USD","LU1934455277.USD","ABBV","LU2347655156.SGD","BK4559","LU0795875086.SGD","PPH","JDOC","LU1989772840.SGD","BK4534","LU0069063385.USD","LU2112291526.USD","LU0211327993.USD","LU1929549753.HKD","LU2089984988.USD","LU1267930490.SGD","IE00BDGV0183.EUR","LU0057025933.USD","LU0170899867.USD","LU0726765562.USD","IE00BBT3K403.USD","LU0128525929.USD","SG9999015952.SGD","LU0912757837.SGD","IYH","LU1061106388.HKD","LU0256863811.USD","LU0545039389.USD","IE00BVYPNV92.GBP","LU2357627491.SGD","LU0965509101.SGD","LU2125909247.SGD","LU0395794307.EUR","LU1093756325.SGD","LU1074936037.SGD","LU2237443465.HKD","LU0882574055.USD","LU1162221912.USD","LU0868494708.USD","RXL","LU2347655073.USD","SG9999015986.USD","BK4139","LU0029864427.USD","LU0661504455.SGD","LU1670627923.USD","SG9999001440.SGD","BK4585","LU1291159041.SGD","LU1551013342.USD","LU1496350171.SGD","LU1057294990.SGD","LU2468319806.SGD","BK4566","LU0320765646.SGD","LU0511384066.AUD","LU1670628061.USD","LU0943347566.SGD","IE00B2B36J28.USD","LU2237443382.USD","LU0823416689.USD","VHT","LU2089283258.USD","IE00BGHQF631.EUR","IE00BN8TJ469.HKD","MEDX","LU1839511570.USD","IE00BFTCPJ56.SGD","SG9999015945.SGD","LU0256863902.USD","LU1923622614.USD","LU0942090050.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664287786","title":"艾伯維的血液癌症藥物達到了晚期臨床試驗的目標","url":"https://stock-news.laohu8.com/highlight/detail?id=2664287786","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664287786?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 21:18","pubTimestamp":1788441535,"startTime":"0","endTime":"0","summary":"艾伯维的血液癌症药物达到了晚期临床试验的目标路透9月3日-艾伯维（AbbVie）ABBV.N周四表示，其用于治疗某类血液癌症的药物已达到一项晚期临床试验的主要目标。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nL4T44V12O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0545039389.USD","MEDX","ABBV","JDOC","IE00B19Z3B42.SGD","LU2125909593.SGD","LU0943347566.SGD","LU0456855351.SGD","RXL","SG9999015945.SGD","LU1244550494.USD","XLV","FHLC","LU1989771016.USD","IXJ","PJP","BK4588","IE000WAW04H5.SGD","LU0234572021.USD","LU1093756325.SGD","LU0861579265.USD","LU0511384066.AUD","SG9999001440.SGD","TRUH","LU1934455194.USD","FTXH","LU1732800096.USD","LU1244550577.SGD","SG9999011175.SGD","LU0289961442.SGD","PPH","LU0795875169.SGD","AGNG","LU0170899867.USD","LU0859254822.USD","IE00B3PB1722.GBP","IE00BBT3K403.USD","LU2089283258.USD","VHT","IYH","LU2237443465.HKD","LU1430594728.SGD","LU1934455863.HKD","LU1839511570.USD","IE00B2B36J28.USD","LU0128525929.USD","LU2237443382.USD","SG9999003800.SGD","GLAM","LU0942090050.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664874779","title":"阿斯彭預計，2027年Mounjaro在非洲的銷售額將超過1.24億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2664874779","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664874779?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 20:37","pubTimestamp":1788439031,"startTime":"0","endTime":"0","summary":"阿斯彭预计，2027年Mounjaro在非洲的销售额将超过1.24亿美元阿斯彭已向肯尼亚和尼日利亚提交了Mounjaro的注册申请截至6月底的这一年度内，南非GLP-1市场规模几乎翻倍，达到28亿兰特阿斯彭计划在部分市场推出奥兹莫皮克仿制药，巴西也在其中Nqobile Dludla路透约翰内斯堡9月3日-阿斯彭制药预计，在南非需求激增以及计划在尼日利亚和肯尼亚上市的推动下，礼来公司旗下LLY.N这款重磅减肥及糖尿病药物Mounjaro在本财年的非洲销售额将超过20亿兰特。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nL4S44V0ZN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LLYZ","LU2462591350.SGD","THNR","SG9999014898.SGD","IE0002141913.USD","SG9999014906.USD","LU0114720955.EUR","LU2168564495.EUR","LU1629891620.HKD","LU0882574139.USD","LU1623119135.USD","TRUH","LU0174119429.USD","LU1868837136.USD","LU0323591593.USD","LU1974910355.USD","BK4516","BK4581","LU2023251221.USD","LU2471134523.USD","LU1868837300.USD","LU1917777945.USD","LU0106261372.USD","LU2168564065.EUR","LU0256863811.USD","SGXZ99366536.SGD","LU1868836591.USD","LU2108987350.USD","LU2237443895.HKD","LU2750360997.AUD","LU1061106388.HKD","LU1989771016.USD","BK4534","LU0109394709.USD","GB00BDT5M118.USD","LU0133085943.USD","IE00BKPKM429.USD","LU2552382215.SGD","LU2168564222.USD","LU2471134796.USD","LU0061475181.USD","IE00BFSS8Q28.SGD","LU1093756325.SGD","BK4533","LU2456880835.USD","LU2112291526.USD","PJP","SG9999015952.SGD","IHE","LU0203202063.USD","LU2237443549.SGD","LU0097036916.USD","LU1093756168.USD","IE00B7KXQ091.USD","LU1548497426.USD","LU0006306889.USD","LU2237443978.SGD","LU2357305700.SGD","LU1868836914.USD","LU2361044865.SGD","XLV","LU2324357040.USD","LU2552382058.USD","ELIL","LU1035775433.USD","LU1988902786.USD","LU2750360641.GBP","LU1979441026.SGD","LU2237438978.USD","LU2361044949.HKD","IE00B775H168.HKD","LU1232071149.USD","LU0456855351.SGD","LU0094547139.USD","LU0820561818.USD","LU0158827781.USD","LU2028103732.USD","BK4585","LU0889565916.HKD","IXJ","LU0079474960.USD","IE00BJJMRZ35.SGD","SG9999001176.SGD","SG9999013999.USD","LU2491049909.HKD","LU1280957306.USD","SG9999018857.SGD","IE00BJLML261.HKD","LU2089984988.USD","LU0471298694.HKD","FHLC","IE00B1XK9C88.USD","GDOC","LU2896262040.SGD","IE00B2B36J28.USD","LU0058720904.USD","LU1804176565.USD","SG9999001176.USD","LU1023059063.AUD","LU1720051108.HKD","IE0001KFT4U8.USD","IE00B4R5TH58.HKD","LU0689472784.USD","LU0109391861.USD","LU2746668461.USD","LLY","LU0786609619.USD","LU0471298777.SGD","LU0640476718.USD","LU0943347566.SGD","HRTS","IE0004445015.USD","LU0466842654.USD","SG9999015945.SGD","LU2602419157.SGD","LU0385154629.USD","APNHY","CANC","LU0320765992.SGD","LU1267930730.SGD","ILDR","IE00BJT1NW94.SGD","LU2023250504.SGD","LU2271345857.HKD","OZEM","SGXZ31699556.SGD","LU2237443622.USD","IE00BJJMRY28.SGD","BK4007","LU1291159041.SGD","LU2746668974.SGD","IE00BN29S564.USD","LU1366192091.USD","IE00BWXC8680.SGD","LU0320765059.SGD","LU2106854487.HKD","SGXZ51526630.SGD","LU0787776722.HKD","LU2023250330.USD","LU0266013472.USD","IE00BKDWB100.SGD","LU0345770308.USD","LU0708995401.HKD","LU0820562030.AUD","RXL","SGXZ81514606.USD","LU0823416689.USD","LU2491050071.SGD","LU1145028129.USD","BK4588","LU2471134952.CNY","LU2461242641.AUD","MEDI","SG9999015978.USD","VHT","LU1064131342.USD","SG9999017495.SGD","LLYX","LU0353189763.USD","SGXZ57979304.SGD","BK4599","LU1868836757.USD","SG9999015986.USD","AGNG","LU1814569148.SGD","MEDX","LU1691799644.USD","IE00BJJMRX11.SGD","LU2552382132.HKD","FTXH","LU0198837287.USD","LU2265009873.SGD","LU2089284900.SGD","LU1069344957.HKD","LU0096364046.USD","LU1323610961.USD","LU0289739699.SGD","LU2236285917.USD","LU2111349929.HKD","LU2211815571.USD","LU2213496289.HKD","LU2471134879.HKD","LU0122379950.USD","IYH","LU0256863902.USD","IE0005OL40V9.USD","LU0203201768.USD","LU0354030511.USD","LU1057294990.SGD","LU1551013342.USD","ELIS","JDOC","LU0432979614.USD","LU1712237335.SGD","LU2756315318.SGD","LU1983299246.USD","CURE","LU0354030438.USD","LU2468319806.SGD","TMED","LU2264538146.SGD","IE00B1BXHZ80.USD","LU2168563687.JPY","LU0820561909.HKD","SG9999018865.SGD","LU0225283273.USD","LU2087625088.SGD","LU0158827948.USD","LU2756315664.SGD","IE00BFSS7M15.SGD","LU2237443382.USD","LU0316494557.USD","LU2168564149.EUR","LU0238689110.USD","PPH","IE00B4JS1V06.HKD","MHIP","IE00BK4W5L77.USD","LU2089283258.USD","LU1127390331.HKD","LU2361045086.USD","LU0882574055.USD","IE00BFTCPJ56.SGD","LU2417539215.USD","IE00BK4W5M84.HKD","LU0353189680.USD","LU0210536198.USD","SG9999014914.USD","LU1551013425.SGD","WDNA","LU0823434583.USD","LU0683600562.USD","LU0234572021.USD","LU0417517546.SGD","LLII","LU1720051017.SGD","LU2063271972.USD","SG9999014880.SGD","LU2462157665.USD","IE0009355771.USD","LU0672654240.SGD","LU0823434740.USD","LU0345770993.USD","LU2237443465.HKD","IE0004445239.USD","LU2360106947.USD","LU0964807845.USD","LU2491050154.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148741481","title":"Superluminal Medicines完成融資：Bvf Partners領投，英偉達、禮來等現有投資方跟投","url":"https://stock-news.laohu8.com/highlight/detail?id=1148741481","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148741481?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 18:09","pubTimestamp":1788430147,"startTime":"0","endTime":"0","summary":"Superluminal Medicines宣布完成新一轮融资，此轮融资由Bvf Partners领投。值得注意的是，包括英伟达、礼来、Cooley以及Gaingels在内的多家现有投资方亦参与了本轮投资，阵容堪称豪华。公司方面并未披露具体细节。投资方跨越科技与生物医药两大领域的布局，似乎也暗示着Superluminal Medicines未来的发展方向可能涉及计算驱动的药物发现。截至目前，Superluminal Medicines尚未透露本次融资的具体金额及公司估值。随着这笔资金的落袋，Superluminal Medicines接下来会有何动作？业界正拭目以待。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELIL","LU2756315664.SGD","LU1244550221.USD","LU0198837287.USD","LU1400636657.SGD","VGT","LU2100268510.USD","LU1699723380.USD","LU2108987350.USD","IE00B775H168.HKD","LU2471134952.CNY","IYH","LU0965509283.SGD","LU0323239441.USD","LU0823434583.USD","LU0342679015.USD","LU2592432038.USD","LLY","NVDY","LU0889565916.HKD","LU2237438978.USD","CLSE","LU2023250330.USD","FHLC","CHAT","LU1244550577.SGD","LU1732800096.USD","LU1551013342.USD","IE00B19Z9505.USD","LU2028103732.USD","LU0943347566.SGD","LU2954938101.SGD","LU0823416689.USD","LU1880398471.USD","BK4543","ANV","LU0081259029.USD","LU0072462426.USD","LU0823421333.USD","LU1992135399.USD","LU0965508806.USD","LU1791710582.SGD","LU0861579265.USD","IHE","LU1551013425.SGD","LU2168564065.EUR","LU1880398554.USD","SG9999000418.SGD","LU0238689110.USD","LU1232071149.USD","NVDL","LU1674673428.USD","LU2602419157.SGD","CURE","LU0109394709.USD","LU1093756325.SGD","LU2125154778.USD","LU2125909247.SGD","LU1803068979.SGD","LU2097344431.USD","SG9999017495.SGD","THNR","LU1548497426.USD","LU0323591593.USD","LU0097036916.USD","JGRO","BK4141","LU2347655073.USD","SGXZ51526630.SGD","NVD2.UK","LU1934455863.HKD","GAMR","LU1868837300.USD","LU2125154935.USD","LU2272731600.USD","LU0471298694.HKD","LU0726765562.USD","LU2077746001.SGD","ROM","LU0053666078.USD","LU2125909593.SGD","LU2461242641.AUD","LLYX","LU0069063385.USD","LU0128525929.USD","NVDX","LU0788109477.HKD","LU1037948541.HKD","BK4599","LU2237443549.SGD","LU2462591350.SGD","LU1119994496.HKD","BK4581","LU2506951792.HKD","LU1116320737.USD","LLYZ","IE00BZ1G4Q59.USD","SMHX","IE00B3S45H60.SGD","LU0267386448.USD","LU0210533765.USD","LU0289960550.SGD","LU2381873111.SGD","LU2286300806.USD","IE0001KFT4U8.USD","LU0528227936.USD","PPH","FTXH","IE0003U64NQ7.SGD","IE00BQXX3D17.EUR","LU0345769128.USD","LU0820562030.AUD","IE00BJT1NW94.SGD","LU1868837136.USD","LU2125909916.SGD","LU2168564222.USD","SG9999015952.SGD","LU0080751232.USD","LU0096362180.USD","LU2361045086.USD","LU1983260115.SGD","LU2543165471.USD","SPTE","LU2360107168.USD","NULC","IE00BFTCPJ56.SGD","NVDA","BK4549","LU1127390331.HKD","LU0158827781.USD","IE00B1XK9C88.USD","SG9999002232.USD","LU0795875169.SGD","IE00BJLML261.HKD","SGXZ99366536.SGD","LU0417517546.SGD","BK4516","LU1084165304.USD","TYLG","LU2326559502.SGD","LU0029864427.USD","LU0203202063.USD","LU2065171402.SGD","HRTS","LU0786609619.USD","LU0106261372.USD","HK0000320264.USD","LU1496350502.SGD","BK4551","LU0133085943.USD","IE0005OL40V9.USD","LU0511384066.AUD","LU2168564495.EUR","LU0289739343.SGD","LU1037948897.HKD","IE000Q6AESB8.SGD","LU1861127337.USD","VHT","LU0011850046.USD","NVDD","SG9999001176.USD","LU0006306889.USD","LU1066051811.HKD","BK4527","LU2244417387.USD","LU0056508442.USD","SG9999014906.USD","NVD","BK4587","LU1951198990.SGD","LU0432979614.USD","LU0640476718.USD","LU1868836757.USD","LU1992135472.HKD","LU2092627202.USD","NVDG","LU1400636574.HKD","LU2265009873.SGD","LU1815336760.USD","LU0820561818.USD","LU0211328371.USD","LU0642271901.SGD","SG9999002224.SGD","SG9999015341.SGD","LU0234570918.USD","IE00B4JS1V06.HKD","LU0545039389.USD","LU2087625088.SGD","LU0265550359.USD","LU2264538146.SGD","LU0096364046.USD","LU2750360641.GBP","LU2111349929.HKD","SGXZ23171101.USD","NVII","LU0345768153.USD","LU0348723411.USD","LU2083900584.USD","SG9999014914.USD","SG9999015945.SGD","LU0672654240.SGD","LU2473716301.USD","SG9999014567.USD","NVDB","LU2999663052.SGD","LU0823414551.USD","LU2047632596.USD","SG9999018865.SGD","BK4605","LU2746668974.SGD","3NVD.UK","LU2089985449.USD","LU1670756490.USD","IE00BJJMRY28.SGD","LU1815333072.USD","LU2491050154.USD","SGXZ31699556.SGD","LU2361044949.HKD","MEDI","LU0689626769.HKD","LU1804176565.USD","CMAG","LU0979878070.USD","OZEM","LU2213496289.HKD","IE0004091025.USD","LU3102509885.SGD","LU0234572021.USD","IE00BJTD4N35.SGD","LU0124676726.USD","LU1935043536.SGD","LU1974910355.USD","LU1145028129.USD","LU2357125470.USD","IE000KEQY171.SGD","LLII","IE0002141913.USD","LU1868836914.USD","LU0316494557.USD","LU2462157665.USD","LU0689472784.USD","LU1861215975.USD","JDOC","LU2242650005.HKD","LU2931357623.SGD","LU1917777945.USD","TMED","TEK","HK0000304805.HKD","IE00B1BXHZ80.USD","LU0444973449.USD","LU1988902786.USD","LU2860962120.EUR","IE00B2B36J28.USD","LU2433249047.HKD","LU0187121727.USD","LU2505996509.AUD","LU1066053197.SGD","LU0795875086.SGD","LU0048584097.USD","LU2463028550.USD","LU1935043023.USD","BK4585","IE00BJJMRX11.SGD","IE00BMPRXQ63.HKD","LU1721428933.USD","WISE","IE00BQXX3C00.GBP","LU2487616109.SGD","IE00BDCRKT87.USD","LU2430703095.HKD","LU2637965513.SGD","LU0094547139.USD","NVDS.UK","LU1571399168.USD","LU0354030438.USD","SMH","LU0957791311.USD","LU0823414478.USD","LU1429558221.USD","LU2322448957.HKD","FDTX","LU0719512351.SGD","IE000W1ABFV2.USD","07788","BK4588","LU1989771016.USD","IE00BYXW3230.USD","LU0058720904.USD","LU0077335932.USD","VT","LU1291159041.SGD","XLK","LU0708995401.HKD","IXN","LU0708994859.HKD","NVD3.UK","DIPS","BK4007","LU1814569148.SGD","LU2357305700.SGD","SG9999014898.SGD","LU0310799852.SGD","BK4548","LU2552382132.HKD","LU0266013472.USD","LU0320765059.SGD","CNEQ","LU1868836591.USD","LU1035775433.USD","BK4550","LU1116320901.HKD","NVC","IE00BJTD4V19.USD","USXF","FAI","LU0889565833.HKD","LU1323610961.USD","SG9999014559.SGD","LU2237443382.USD","SOXQ","IE00B5949003.HKD","LU2456880835.USD","BK4529","LU0354030511.USD","LU2242649171.HKD","LU1778281490.HKD","LU2148611432.USD","NVDS","LU1923622614.USD","LU2471134796.USD","LU2420271590.USD","BK4532","LU1244550494.USD","09788","IE00BK4W5M84.HKD","HK0000532082.HKD","LU0070217475.USD","LU0957808578.USD","LU1400636491.USD","LU2168563687.JPY","CANC","LU2430703178.SGD","LU0823434740.USD","FTEC","LU1934455277.USD","LU1066051498.USD","BK4503","IE00BFSS8Q28.SGD","LU2394011477.USD","IE00BN29S564.USD","SGXZ81514606.USD","LU2360032135.SGD","LU2133065610.SGD","LU2896262040.SGD","IE00BFSS7M15.SGD","LU0553294199.USD","IE0009355771.USD","BK4592","NVDO","LU1066051225.USD","IE00BMPRXN33.USD","HK0000306701.USD","LU2417539215.USD","TTXU","LU0949170772.SGD","IE0009G5SDU7.USD","LU2294711713.HKD","LU0170899867.USD","SOXY","LU0138981039.USD","LU0215105999.USD","LU2458330243.SGD","LU0466842654.USD","SG9999013999.USD","LU0061475181.USD","LU1645745479.HKD","AIFD","LU1791710400.SGD","NVDU","SNPE","ELIS","LU0390134368.USD","SGXZ80539844.SGD","LU1923623000.USD","LU1989772923.USD","IE00BMPRXR70.SGD","LU2458330169.SGD","PJP","LU2471134879.HKD","IE0004086264.USD","LU0079474960.USD","LU0942090050.USD","SG9999015978.USD","IXJ","LU2092937148.SGD","BK4533","LU2211815571.USD","EFIV","IE00BKDWB100.SGD","ESLG","BK4534","LU1989764664.SGD","LU0210528500.USD","LU1003077747.HKD","LU2360106947.USD","LU1069347547.HKD","ABFL","LU1267930490.SGD","LU2279689827.SGD","07388","LU0456855351.SGD","LU0345770993.USD","SOXX","IE00B4YYXB79.USD","XLV","LU0154236417.USD","LU2250418816.HKD","LU0965509101.SGD","RXL","LU0114720955.EUR","LU0661504455.SGD","09388","IE00BKPKM429.USD","METV","IE00BD6J9T35.USD","BK4598","LU1316542783.SGD","LU0912757837.SGD","LU2272731782.SGD","LU0823421416.USD","LU1242518931.SGD","LU1712237335.SGD","SGXZ57979304.SGD","LU1064131342.USD","LU0385154629.USD","LU0868494617.USD","LU1720051108.HKD","GB00BDT5M118.USD","IE00BHPRN162.USD","LU1267930573.SGD","LU2065171311.SGD","LU2089283258.USD","SG9999014880.SGD","HK0000914660.USD","LU0882574055.USD","IE0004445239.USD","IETC","LU0109392836.USD","LU0345770308.USD","LU0122379950.USD","LU2491049909.HKD","SNVDAmain","IE00B3SWFQ91.USD","LU0353189680.USD","LU1983299246.USD","2NVD.UK","LU1280957306.USD","LU1629891620.HKD","LU2552382215.SGD","LU2087621335.USD","SG9999001176.SGD","THMR","LU1242518857.USD","LU0225283273.USD","LU0289739699.SGD","LU0109391861.USD","LU2471134523.USD","AGOX","LU2290526834.HKD","LU2247934214.USD","LU0158827948.USD","LU2361044865.SGD","USD","IE0034235303.USD","IE000ITXATA3.USD","LU0061474960.USD","HK0000914686.HKD","LU1821325948.USD","CHPX","SG9999004303.SGD","LU0256863811.USD","LU2746668461.USD","LU0310800379.SGD","LU0353189763.USD","LU2403377893.USD","LU2347655156.SGD","TRUH","LU1144417596.USD","LU1153585028.USD","HK0000304797.USD","LU0724617625.USD","LU2505996681.GBP","LU1061106388.HKD","LU2237957902.USD","LU2237443895.HKD","NVDQ","LU0061474705.USD","LU0143551892.USD","LU1633808545.USD","AGNG","LU1202635105.USD","LU1691799644.USD","LU2237443465.HKD","IE000YTNTUN2.SGD","LU1496350171.SGD","LU0251132253.USD","LU0157215616.USD","SG9999014542.SGD","LFGY","LU1057294990.SGD","LU1366192091.USD","LU2191332357.HKD","LU2750360997.AUD","WDNA","LU0557290698.USD","IE00B4R5TH58.HKD","LU0471298777.SGD","LU0444971666.USD","LU2097344357.USD","SG9999018857.SGD","LU1979441026.SGD","IE00BZ199S13.USD","BK4579","LU1934455194.USD","LU2063271972.USD","BK4614","LU1732799900.SGD","LU1989764748.USD","LU0127658192.USD","LU0175139822.USD","IE0004445015.USD","LU0964807845.USD","LU2552382058.USD","TTEQ","LU1839511570.USD","LU1642822529.SGD","LU0345768740.USD","LU0965509010.AUD","LU1069344957.HKD","LU1914381329.SGD","BK4554","IE00B7KXQ091.USD","LU1989772840.SGD","IE00B5TLWC47.USD","LU1366333091.USD","SG9999001424.SGD","NVDW","LU0265550946.USD","LU2430703251.USD","SG9999015358.SGD","BK4567","LU0203201768.USD","LU0494093205.USD","IE00BQXX3F31.USD","LU0174119429.USD","LU0787776722.HKD","LU2065169927.USD","LU0868494708.USD","LU0210536198.USD","LU2271345857.HKD","IE00BDRTCR15.USD","TRFK","LU1935042991.SGD","IE0034235188.USD","LU0289961442.SGD","BK4608","LU2112291526.USD","IE00B19Z8X17.USD","SHOC","LU0276348264.USD","LU2322448791.USD","GDOC","AIPI","LU1852331112.SGD","IE00B775SV38.USD","LU2065170008.USD","LU0476273544.USD","LU2324357040.USD","LU2237443978.SGD","IE00B3M56506.USD","LU0211327993.USD","HK0000819398.USD","ARTY","LU2089984988.USD","ESUM","LU2054465674.USD","LU0308772762.SGD","LU2452424414.USD","SNVD.UK","HK0000320223.HKD","LU1951200564.SGD","LU2756315318.SGD","LU0082616367.USD","LU1720051017.SGD","LU2106854487.HKD","LU0057025933.USD","LU1674673691.USD","LU0274383776.USD","LU0395794307.EUR","IE00B19Z8W00.USD","IE00BJJMRZ35.SGD","BK4612","LU2237443622.USD","LU2462591277.SGD","SG9999014575.USD","IE0034235295.USD","LU0820561909.HKD","LU1935042488.USD","LU1935042215.USD","LU0320765992.SGD","LU1718418525.SGD","LU0323240290.USD","LU0738911758.USD","LU1435385759.SGD","LU1623119135.USD","NVYY","LU2237957811.SGD","LU0683600562.USD","LU2360106780.USD","HK0000306685.HKD","MHIP","LU2125909759.SGD","IE00BWXC8680.SGD","NVIW.SI","LU2413666426.HKD","LU2168564149.EUR","LU0882574139.USD","IE00BK4W5L77.USD","ILDR","LU1267930730.SGD","IE0009356076.USD","LU0107464264.USD","LU1035773651.USD","LU2468319806.SGD","LU2272731865.HKD","LU1261432733.SGD","LU2236285917.USD","MEDX","LU1923622291.USD","LU2023251221.USD","LU2413666699.HKD","LU0345769631.USD","LU1093756168.USD","SG9999015986.USD","LU1861220033.SGD","LU0472753341.HKD","IE00BKVL7J92.USD","LU2491050071.SGD","LU2089284900.SGD","LU2249611893.SGD","LU0347712357.USD","LU2023250504.SGD","LU1023059063.AUD","LU0256863902.USD","LU0985320562.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}